FOLH1 and cancer: Cancer-specific CTC marks such as epidermal growth factor receptor-2 (HER2), prostate-specific membrane antigen (PSMA), estrogen receptor, folate receptor, and survivin are in accordance with the specific molecular markers of the primary tumor [14].